WHO ICTRP trial
Optimalisation of vancomycine dosage regimens in pediatric patients
NL-OMON30777 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON30777 |
|---|---|
| Public title | Optimalisation of vancomycine dosage regimens in pediatric patients |
| Scientific title | Optimalisation of vancomycine dosage regimens in pediatric patients - VANCOPED |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | blood poisoning serious infection;10004018;blood poisoning;serious infection |
| Interventions | Half of the included number of patients will receive a higher vancomycin dosage at the start of therapy. However this dosage is within the limits of the normal dosage range. ;children;dosage;pharmacokinetics;vancomycine |
| Registration date | Aug 28, 2007 |
| Target size | 200 |
| Secondary IDs | 2006-003112-22;NL12574.018.06 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: